Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term OutcomesKristine Broglio, Donald A. Berry, Melanie Quintana et al.|JAMA Oncology|2016Cited by 375
The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression modelRandall J. Bateman, Chengjie Xiong, Anna Santacruz et al.|Alzheimer s & Dementia|2016Cited by 303
A novel cognitive disease progression model for clinical trials in autosomal‐dominant Alzheimer's diseaseGuoqiao Wang, Scott Berry, Chengjie Xiong et al.|Statistics in Medicine|2018Cited by 65
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 studyNuria Carrillo, William A. Gahl, May Christine V. Malicdan et al.|Genetics in Medicine|2021Cited by 55
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomizationAlexandra R. Brown, Richard J. Barohn, Byron J. Gajewski et al.|Trials|2016Cited by 26